{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "INO",
    "data": {
        "bs": [
            {
                "label": "Deferred tax liabilities",
                "concept": "DeferredIncomeTaxLiabilitiesNet",
                "unit": "usd",
                "value": 32046
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -1042738901
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -1000000000.0
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 58925302
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entities",
                "concept": "ino:PrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": 303491
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "ino:AccruedClinicalTrialExpenseCurrent",
                "unit": "usd",
                "value": 10416164
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -265909
            },
            {
                "label": "Preferred stock",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 542424625
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 591842169
            },
            {
                "label": "Grant funding liability",
                "concept": "ino:DeferredGrantFundingCurrent",
                "unit": "usd",
                "value": 6859155
            },
            {
                "label": "Grant funding liability from affiliated entities",
                "concept": "ino:DeferredGrantFundingFromAffiliateCurrent",
                "unit": "usd",
                "value": 31250
            },
            {
                "label": "Fixed assets, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 18111288
            },
            {
                "label": "Operating lease liability, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 16797476
            },
            {
                "label": "Operating lease liability, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 16797000
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 2879896
            },
            {
                "label": "Intangible assets, net",
                "concept": "IntangibleAssetsNetExcludingGoodwill",
                "unit": "usd",
                "value": 2900000.0
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 10513371
            },
            {
                "label": "Goodwill",
                "concept": "Goodwill",
                "unit": "usd",
                "value": 10513371
            },
            {
                "label": "Deferred revenue, net of current portion",
                "concept": "ContractWithCustomerLiabilityNoncurrent",
                "unit": "usd",
                "value": 71788
            },
            {
                "label": "Deferred revenue",
                "concept": "ContractWithCustomerLiabilityCurrent",
                "unit": "usd",
                "value": 109128
            },
            {
                "label": "Accounts receivable from affiliated entities",
                "concept": "AccountsReceivableRelatedPartiesCurrent",
                "unit": "usd",
                "value": 722941
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "AccountsPayableAndAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 30095578
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 64141
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entities",
                "concept": "DueToRelatedPartiesCurrent",
                "unit": "usd",
                "value": 1773846
            },
            {
                "label": "Short-term investments",
                "concept": "ShortTermInvestments",
                "unit": "usd",
                "value": 384752382
            },
            {
                "label": "Grant funding liability from affiliated entity, net of current portion",
                "concept": "ino:DeferredGrantFundingFromAffiliateNoncurrent",
                "unit": "usd",
                "value": 37500
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 83288398
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 13128330
            },
            {
                "label": "Total liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 591842169
            },
            {
                "label": "Investment in affiliated entity",
                "concept": "EquitySecuritiesFvNiCurrentAndNoncurrent",
                "unit": "usd",
                "value": 3908709
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 84592179
            },
            {
                "label": "Total Inovio Pharmaceuticals, Inc. stockholders\u2019 equity",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 508553771
            },
            {
                "label": "Operating lease right-of-use assets",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 12173414
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 1830866
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 1551348435
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 2463878
            },
            {
                "label": "Operating lease liability",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 2464000
            },
            {
                "label": "Investment in Geneos",
                "concept": "EquityMethodInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 51748999
            },
            {
                "label": "Common stock",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 210146
            }
        ],
        "cf": [
            {
                "label": "Depreciation",
                "concept": "Depreciation",
                "unit": "usd",
                "value": 1361595
            },
            {
                "label": "Interest paid",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 544315
            },
            {
                "label": "Accounts receivable from affiliated entities",
                "concept": "IncreaseDecreaseInAccountsReceivableRelatedParties",
                "unit": "usd",
                "value": 219159
            },
            {
                "label": "Prepaid expenses and other current assets from affiliated entities",
                "concept": "ino:IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssetsFromAffiliatedEntity",
                "unit": "usd",
                "value": 197059
            },
            {
                "label": "(Decrease) Increase in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": -191802816
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -131326659
            },
            {
                "label": "Acquisition of non-controlling interest",
                "concept": "ProceedsFromMinorityShareholders",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 164344664
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -5431637
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 266874
            },
            {
                "label": "Amortization of intangible assets",
                "concept": "AmortizationOfIntangibleAssets",
                "unit": "usd",
                "value": 267000
            },
            {
                "label": "Accounts payable and accrued expenses due to affiliated entities",
                "concept": "IncreaseDecreaseInAccountsPayableRelatedParties",
                "unit": "usd",
                "value": 1130877
            },
            {
                "label": "Taxes paid related to net share settlement of equity awards",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 3915160
            },
            {
                "label": "Effect of exchange rate changes on cash and cash equivalents",
                "concept": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
                "unit": "usd",
                "value": -11941
            },
            {
                "label": "Unrealized transaction gain on foreign-currency denominated debt",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": 176927
            },
            {
                "label": "Proceeds from stock option exercises",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 6154794
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Amounts accrued for purchases of property and equipment",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Purchases of capital assets",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 418734
            },
            {
                "label": "Proceeds from Geneos issuance of note payable",
                "concept": "ProceedsFromNotesPayable",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "IncreaseDecreaseInDerivativeLiabilities",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Decrease in cash resulting from the deconsolidation of Geneos",
                "concept": "CashDivestedFromDeconsolidation",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Deferred revenue from affiliated entities",
                "concept": "ino:IncreaseDecreaseInDeferredRevenueFromRelatedParties",
                "unit": "usd",
                "value": -6250
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 15242305
            },
            {
                "label": "Gain (loss) on equity investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -551657
            },
            {
                "label": "Gain (loss) on equity investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -551657
            },
            {
                "label": "Share of net loss in Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -434387
            },
            {
                "label": "Share of net loss in Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -434387
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": 51944060
            },
            {
                "label": "Settlement of receivable with shares of common stock from affiliated entity (PLS)",
                "concept": "ino:SettlementOfReceivableWithSharesOfCommonStockFromEquitySecurity",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Operating lease right-of-use assets and liabilities, net",
                "concept": "ino:IncreaseDecreaseInOperatingLeaseRightOfUseAssetLeaseLiabilityNet",
                "unit": "usd",
                "value": -1131555
            },
            {
                "label": "Proceeds from issuance of common stock, net of issuance costs",
                "concept": "ProceedsFromIssuanceOfCommonStock",
                "unit": "usd",
                "value": 162105030
            },
            {
                "label": "(Gain) loss on short-term investments",
                "concept": "GainLossOnInvestments",
                "unit": "usd",
                "value": 153252
            },
            {
                "label": "Proceeds from sale or maturity of investments",
                "concept": "ProceedsFromSaleOfShortTermInvestments",
                "unit": "usd",
                "value": 83466967
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": 8891770
            },
            {
                "label": "Other liabilities",
                "concept": "IncreaseDecreaseInOtherOperatingLiabilities",
                "unit": "usd",
                "value": 6478
            },
            {
                "label": "Non-cash interest expense",
                "concept": "ino:NonCashInterestIncomeExpense",
                "unit": "usd",
                "value": -435445
            },
            {
                "label": "Purchases of investments",
                "concept": "PaymentsToAcquireShortTermInvestments",
                "unit": "usd",
                "value": 307857113
            },
            {
                "label": "Grant funding liability from affiliated entities",
                "concept": "ino:IncreaseDecreaseinDeferredGrantFundingFromAffiliateCurrent",
                "unit": "usd",
                "value": -21000
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -224808880
            },
            {
                "label": "Non-cash lease expense",
                "concept": "ino:OperatingLeaseNonCashLeaseExpense",
                "unit": "usd",
                "value": 567882
            },
            {
                "label": "Net unrealized loss on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedLoss",
                "unit": "usd",
                "value": 711465
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": -24126582
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInContractWithCustomerLiability",
                "unit": "usd",
                "value": 55074
            },
            {
                "label": "Accrued clinical trial expenses",
                "concept": "ino:IncreaseDecreaseInAccruedClinicalTrialExpense",
                "unit": "usd",
                "value": 465819
            },
            {
                "label": "Grant funding liability",
                "concept": "ino:IncreaseDecreaseinDeferredGrantFundingCurrent",
                "unit": "usd",
                "value": -615155
            }
        ],
        "ic": [
            {
                "label": "Interest income",
                "concept": "InterestIncomeOperating",
                "unit": "usd",
                "value": 1697347
            },
            {
                "label": "Total revenues",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 643945
            },
            {
                "label": "Diluted (in shares)",
                "concept": "WeightedAverageNumberOfDilutedSharesOutstanding",
                "unit": "shares",
                "value": "N/A"
            },
            {
                "label": "Basic (in shares)",
                "concept": "WeightedAverageNumberOfSharesOutstandingBasic",
                "unit": "shares",
                "value": 206007497
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 109852836
            },
            {
                "label": "Change in fair value of derivative liability",
                "concept": "EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 136400371
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 979760
            },
            {
                "label": "Net unrealized gain (loss) on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedGainLoss",
                "unit": "usd",
                "value": -711465
            },
            {
                "label": "Net unrealized gain (loss) on available-for-sale equity securities",
                "concept": "EquitySecuritiesFvNiUnrealizedGainLoss",
                "unit": "usd",
                "value": -711000
            },
            {
                "label": "Net loss before share in net loss of Geneos",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -136107702
            },
            {
                "label": "Net loss attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Net loss attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -136500000.0
            },
            {
                "label": "Net loss attributable to non-controlling interest",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Gain on deconsolidation of Geneos",
                "concept": "DeconsolidationGainOrLossAmount",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 194259
            },
            {
                "label": "Basic (in dollars per share)",
                "concept": "EarningsPerShareBasic",
                "unit": "usd/shares",
                "value": -0.66
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Share in net loss of Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -434387
            },
            {
                "label": "Share in net loss of Geneos",
                "concept": "IncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -434387
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -135756426
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 26547535
            },
            {
                "label": "Diluted (in dollars per share)",
                "concept": "EarningsPerShareDiluted",
                "unit": "usd/shares",
                "value": ""
            },
            {
                "label": "Gain (loss) on investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -551657
            },
            {
                "label": "Gain (loss) on investment in affiliated entities",
                "concept": "ino:ChangeInValueOfInvestmentsInAffiliatedCompany",
                "unit": "usd",
                "value": -551657
            },
            {
                "label": "Comprehensive loss attributable to Inovio Pharmaceuticals, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -136551848
            },
            {
                "label": "Foreign currency translation",
                "concept": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
                "unit": "usd",
                "value": -11941
            },
            {
                "label": "Unrealized gain (loss) on short-term investments, net of tax",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 2182
            },
            {
                "label": "Comprehensive loss attributable to non-controlling interest",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -136542089
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -136551848
            }
        ]
    }
}